Adv Infection clinical trials

Explore recruiting adv infection clinical trials.

Recruiting adv infection studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adv Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and AdV: A phase III, prospective, multicentre clinical trial (TRACE)

Belgium, Germany, Italy, France, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Adv Infection trials by city

Adv Infection in Toronto Adv Infection in Vancouver Adv Infection in Montreal Adv Infection in Calgary Adv Infection in Edmonton Adv Infection in Ottawa Adv Infection in Winnipeg Adv Infection in Quebec City Adv Infection in Hamilton Adv Infection in Kitchener Adv Infection in London Adv Infection in Halifax Adv Infection in New York Adv Infection in Los Angeles Adv Infection in Chicago Adv Infection in Houston

Adv Infection clinical trials

Recruiting adv infection studies right now

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases

Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

R-MVST Cells for Treatment of Viral Infections

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Also recruiting in Europe

Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and AdV: A phase III, prospective, multicentre clinical trial (TRACE)

Adv Infection trials by city

Other conditions